Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bickham

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Ecotoxicology and Environmental Safety|February 29, 2008
In situ biomonitoring of PAH-contaminated sediments using juvenile coho salmon (Oncorhynchus kisutch)Gary C Barbee, John Barich, Bruce Duncan, et al.
Vaccine|February 25, 2023
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)Thomas Benfield, Mika Rämet, Piero Valentini, et al.
Ecotoxicology (London, England)|December 19, 2003
Chemical contaminants and their effects in fish and wildlife from the industrial zone of Sumgayit, Republic of AzerbaijanCarol D Swartz, K C Donnelly, Arif Islamzadeh, et al.
Vaccine|September 23, 2022
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, et al.
The Pediatric Infectious Disease Journal|August 11, 2023
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three StudiesTimothy J Chapman, Shrita M Patel, Sheryl A Flores, et al.
Obstetrics and Gynecology|November 14, 2023
Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020Ashley Townes, Mary R Tanner, Lei Yu, et al.
Plos Neglected Tropical Diseases|May 17, 2017
The Biomphalaria glabrata DNA methylation machinery displays spatial tissue expression, is differentially active in distinct snail populations and is modulated by interactions with Schistosoma mansoniKathrin K Geyer, Umar H Niazi, David Duval, et al.
AIDS (London, England)|March 20, 2023
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVMarissa Wilck, Shaun Barnabas, Kulkanya Chokephaibulkit, et al.
Vaccine|December 15, 2022
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)Androniki Bili, Scott Dobson, Jeffrey Quinones, et al.
Blood Advances|November 16, 2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) studyCharles T Quinn, Richard T Wiedmann, Daniel Jarovsky, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Ecotoxicology and Environmental Safety|February 29, 2008
In situ biomonitoring of PAH-contaminated sediments using juvenile coho salmon (Oncorhynchus kisutch)Gary C Barbee, John Barich, Bruce Duncan, et al.
Vaccine|February 25, 2023
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)Thomas Benfield, Mika Rämet, Piero Valentini, et al.
Ecotoxicology (London, England)|December 19, 2003
Chemical contaminants and their effects in fish and wildlife from the industrial zone of Sumgayit, Republic of AzerbaijanCarol D Swartz, K C Donnelly, Arif Islamzadeh, et al.
Vaccine|September 23, 2022
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)Natalie Banniettis, Jacek Wysocki, Leszek Szenborn, et al.
The Pediatric Infectious Disease Journal|August 11, 2023
Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three StudiesTimothy J Chapman, Shrita M Patel, Sheryl A Flores, et al.
Obstetrics and Gynecology|November 14, 2023
Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020Ashley Townes, Mary R Tanner, Lei Yu, et al.
Plos Neglected Tropical Diseases|May 17, 2017
The Biomphalaria glabrata DNA methylation machinery displays spatial tissue expression, is differentially active in distinct snail populations and is modulated by interactions with Schistosoma mansoniKathrin K Geyer, Umar H Niazi, David Duval, et al.
AIDS (London, England)|March 20, 2023
A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIVMarissa Wilck, Shaun Barnabas, Kulkanya Chokephaibulkit, et al.
Vaccine|December 15, 2022
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)Androniki Bili, Scott Dobson, Jeffrey Quinones, et al.
Blood Advances|November 16, 2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) studyCharles T Quinn, Richard T Wiedmann, Daniel Jarovsky, et al.
Pageof 24